We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Dentists Identify Breast Cancer from Saliva Proteins

By Labmedica staff writers
Posted on 23 Jan 2008
Protein markers in saliva can distinguish women with breast cancer from those with benign tumors and those with healthy cells. More...
These findings potentially could enable dentists and physicians to detect breast cancer during routine office visits.

A study was performed to determine whether protein byproducts secondary to cancer- related oncogenes appear in the saliva of breast cancer patients. Dr. Charles Streckfus, professor of diagnostic sciences at the University of Texas (UT) Health Science Center (Houston, TX, USA) and colleagues analyzed saliva samples from 30 women--10 with benign tumors, 10 with malignant tumors, and 10 without tumors. They found 49 proteins that differentiated between the women with tumors and those without. In a previous study, Prof. Streckfus identified 85% of malignancies with one differing breast cancer protein; a rate he estimated could approach 95% if additional proteins were analyzed.

In this study, with additional analysis, the scientists were able to distinguish between benign and malignant tumors. According to Prof. Streckfus, the extra analysis could help eliminate false-positive results and allow doctors to determine the next treatment options for women with breast cancer.

A large, multicenter trial is planned in about two years at the UT M.D. Anderson Cancer Center (Houston, Texas, USA) and the UT Dental Branch (Houston, Texas, USA). The proposed test will be conducted on a gold-plated chip or lab dish. A laser will then be used to distinguish protein markers in saliva applied to the chip. Such a test would be used in conjunction with other tools, including mammograms. There are currently no blood tests available for detecting breast cancer.

"This will be a noninvasive, quick means of detection,” Prof. Streckfus said about the new test. "With it, dentists will be able to catch cancers before a woman can feel a lump.”

Prof. Streckfus noted that the test could be useful for breast cancer survivors who need to be monitored regularly and also in developing countries that lack mammography technology.


Related Links:
University of Texas Health Science Center
M.D. Anderson Cancer Center
University of Texas Dental Branch

New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Portable Electronic Pipette
Mini 96
ESR Analyzer
TEST1 2.0
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Elecsys Dengue Ag assay is intended for the in vitro qualitative detection of dengue virus NS1 antigen in human serum and plasma (Photo courtesy of Roche)

Automated Test Distinguishes Dengue from Acute Fever-Causing Illnesses In 18 Minutes

Dengue fever remains the most common mosquito-borne viral infection worldwide, posing a major public health challenge as global cases continue to surge. In 2024 alone, more than 14.6 million infections... Read more

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.